Overview
Corticale S.r.l. is a neurotechnology company developing next-generation high-density CMOS-based neural interfaces for advanced Brain-Computer Interface (BCI) applications. Leveraging its proprietary SiNAPS technology, Corticale has created implantable neural devices capable of recording neural activity through more than 1,000 contacts per implant, enabling unprecedented signal resolution, scalability, and data quality. Operating at the intersection of neuroscience, microelectronics, and artificial intelligence, the company is advancing a new generation of high-performance BCI platforms aimed at restoring communication and motor functions in patients affected by severe neurological conditions.
More in Neurotechnology
Latest industry news
Google and HHMI Janelia Publish the Complete Fruit Fly Brain Connectome — Built With AI
2026-09-28 · Research
St. Jude Wins FDA Approval for Neurostimulation Device Patients Can Upgrade Without Surgery
2026-09-28 · Policy
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Target Neuroscience
2026-09-27 · Funding
At-Home Neuromodulation Devices Are Moving Depression Treatment Out of the Clinic
2026-09-26 · Product
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →